Search

"Phages? We don't use those here." This week, learn how these words propelled Sandro Sulakvelidze, fresh from phage-friendly Tbilisi, into a 25+ year journey to build a phage company with FDA-approved products. From a chance conversation ab

This month we heard about how Sartorius' columns can bring down endotoxins close to zero. There's also a new phage data resource called Phage Base! Lastly, we also picked a couple of super interesting papers this month — one about how antib

How do we remove impurities from our phage preparations, and get our endotoxins down close to zero? This week we've got Ažbe Žnidaršič and Lucija Rebula from Sartorius BIA Separations here to tell us about how CIMmultus monolith chromatogra

This week, Dr. Elisabet More, Principal Scientist at PDB Biotech, shares how phages can be used as diagnostics, and how they use phages to detect M. tuberculosis hidden by the immune system. Although the use of bacteriophages for therapy is

This week we bring you a guest post from CARB-X, which covers how SNIPR Biome uses CRISPR phages to target E. coli with sharpshooter precision. We were recently invited by CARB-X to re-publish a Spotlight article written by Robin Berghaus

Adam Yang, an intern at Shanghai Institute of Phage, interviewed the co-founder of CreatiPhage, Nannan Wu. CreatiPhage is the first company applying phage therapy to humans in China, and seeks to promote the overall development of phage the

This week, Ruby CY Lin of Phage Australia dives further into commercialization pathways and opportunities for Phage Australia, and the phage industry as a whole. In Part Two of this three-part series, she explores possible phage therapy in

Phage Futures Europe was recently held in Amsterdam, where the phage biotech field came together to discuss recent progress in clinical phage therapy and commercialization. Jessica Neubauer and Madhav Madurantakam Royam are back this week w

Last month Madhav Madurantakam Royam and Jessica Neubauer attended Phage Futures Europe in Amsterdam, and they've brought us a sneak-peek into what they learned! The 6th annual Phage Futures conference was held on the 6th and 7th July 2022

This week Madhav Madurantakam Royam, a PhD student at the University of Warwick, talks to Dr. Alexander Sulakvelidze, founder and CEO of Intralytix, one of the first modern phage companies to have products on the market. This week Madhav Ma

A bioreactor should provide the ideal environment for cells (and by extension, phages!). But choosing your setup can be tough. This week, Robert Matthew from Cellexus provides a nice explainer to help you understand your options! The role o

This week, we've got a discussion on the advantages, disadvantages and comparative costs of single use bioreactors vs. traditional solutions, written by Adam Ostrowski, Technical Application Specialist at Cellexus. Every development process

This week, McMaster University PhD student Kyle Jackson interviews Cytophage and BiomX executives, who share phage therapy commercialization challenges and progress and a sneak peek into what they'll present at Phage Futures. You can also

This week, Kyle Jackson (PhD student at McMaster University) brings us a profile of Adaptive Phage Therapeutics, the clinical-stage phage biotech company commercializing the US Navy's phage collection. This is the first in a new column Kyle

For this week's feature article, we interviewed Dr. Arkadiusz Wojtasik, a Production Director at Proteon Pharmaceuticals, about how his team uses the Cellexus CellMaker to produce phage for livestock farming. Phage manufacturing is a known

The NCTC in England has freshly re-characterized 100 phages originally collected for bacterial typing in the 1950s-1990s. If you want your phages to last as long as these, this is a great place to deposit! The National Collection of Type Cu

This week, we interviewed Dr. Manuel Garrido, a Production Specialist at TechnoPhage, about how they've scaled their phage manufacturing with the help of the Cellexus CellMaker. Phage manufacturing seems to be a bottleneck for the global ph

This week, we interviewed Gavin Hands, CEO of Cellexus, about the company's history of helping phage researchers and biotech companies scale up their phage production. This week, we bring you a Q&A with Gavin Hands, CEO of Cellexus. This p

This week, Dr. Michela Gambino, a postdoc in the PHAGEBio group at the University of Copenhagen, tells us about the importance of pork in Denmark, and about their group's search for phages against E. coli in pigs. ## The importance of being

This week, Milan Buňata of MB Pharma, a Czech company that's recently gotten into phage, tells us about phage therapy traditions in the Czech Republic, what their company is working toward, and their interest in collaborating with the phage